• Tassone B , Saoncella S , Neri F, Ala U , Brusa D , Magnuson MA , Provero P, Oliviero S, Riganti C and Calautti E. Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis. Cell Death and Diff 2017
  • Bosia C, Sgrò F, Conti L, Baldassi C, Brusa D, Cavallo F, Di Cunto F, Turco E, Pagnani A and Zecchina R. RNAs competing for microRNAs mutually infuence their fluctuations in a highly non-linear microRNA-dependent manner in single cells. Genom Biol 2017
  • Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D. miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer. Cancer Res 2016
  • Bologna C, Buonincontri R, Serra S, Vaisitti T, Audrito V, Brusa D, Pagnani A, Coscia M, D’Arena G, Mereu E, Piva R, Furman RR, Rossi D, Gaidano G, Terhorst C, Deaglio S. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. JCI 2015
  • Massi D*, Brusa D*, Merelli B, Ciano M, Audrito V, Serra S, Buonincontri R, Baroni G, Nassini R, Minocci D, Cattaneo L, Tamborini E, Carobbio A, Deaglio S§, Mandalà M§. PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. *co-first and §co-last authors. Annals of Oncology, 2014
  • Rolla S, Bardina B, De Mercanti S, Quaglino P, De Palma R, Gned D, Brusa D, Durelli L, Novelli F, Clerico M. Th22 cells are expanded in multiple sclerosis and are resistant to IFNβ. Journal of Leukocyte Biology 2014
  • Brusa D, Simone M, Gontero P, Spadi R, Racca P,  Micari J, Degiuli M, Carletto S, Tizzani A, Matera L. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. Int J Urol. 2013